Whole genome sequencing ofMycobacterium tuberculosis

Authors:

Abstract
Next Generation Sequencing (NGS) technologies using massively parallel processing to interrogate pathogen genomes in days are revolutionising the clinical microbiology practice [1]. Whole genome sequencing (WGS) offers unprecedented resolution for genotyping, outbreak investigation and determination of known sequence variants involved in antimicrobial resistance (AMR), which deep sequencing of selected genomic regions (targeted NGS, tNGS) can further illuminate. WGS-based approach has been proposed for surveillance of bacterial pathogens included in the “priority list” by the World Health Organization (WHO) [2]. At present, proof-of-principle and validation studies have been conducted for WGS from culture samples of Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus, Streptococcus pneumoniae, Pseudomonas aeruginosa, Salmonella spp., Acinetobacter spp., Neisseria gonorrhoeae and Clostridium difficile included in this list, in addition to the globally established priority group Mycobacteria spp. (including Mycobacterium tuberculosis, MTB) [3].

This publication has 27 references indexed in Scilit: